Taro Pharmaceutical Industries Ltd (NYSE:TARO)

74.19
Delayed Data
As of May 14
 +0.24 / +0.32%
Today’s Change
53.95
Today|||52-Week Range
80.00
+1.05%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 81.00, with a high estimate of 81.00 and a low estimate of 81.00. The median estimate represents a +9.18% increase from the last price of 74.19.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.92
Sales
$147.3M
Reporting Date
May 19

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.98%
 
 
 
 
 
 
Growthannually -232.44%
 
 
 
 
 
 

Sales

Growthquarterly 5.12%
 
 
 
 
 
 
Growthannually -15.02%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.